Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
The induction of broadly neutralizing antibodies (bNAbs) is a goal of HIV-1 vaccine research. Here the authors demonstrate the ability of an HIV Env-derived immunogen to bind germline precursors of a class of bNAbs and to activate the corresponding B cells in a knock-in mouse model
Guardado en:
Autores principales: | Andrew T. McGuire, Matthew D. Gray, Pia Dosenovic, Alexander D. Gitlin, Natalia T. Freund, John Petersen, Colin Correnti, William Johnsen, Robert Kegel, Andrew B. Stuart, Jolene Glenn, Michael S. Seaman, William R. Schief, Roland K. Strong, Michel C. Nussenzweig, Leonidas Stamatatos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9b9f94f37144c97936aee7cddb44bba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
por: Aleksandar Antanasijevic, et al.
Publicado: (2021) -
A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques
por: Sujin Lee, et al.
Publicado: (2016) -
Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies
por: Teena Mohan, et al.
Publicado: (2018) -
Development of non-transgenic glyphosate tolerant wheat by TILLING.
por: Charles P Moehs, et al.
Publicado: (2021) -
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Nicholas K. Hurlburt, et al.
Publicado: (2020)